Allogene Therapeutics, Inc. (ALLO)
NASDAQ: ALLO · Real-Time Price · USD
1.040
-0.050 (-4.59%)
At close: Nov 6, 2026, 4:00 PM EST
1.060
+0.020 (1.92%)
After-hours: Nov 6, 2026, 7:57 PM EST
Allogene Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | - | 51.69 | 75.22 | 83.16 | 61.9 | 173.31 |
Short-Term Investments | - | 198.52 | 217.26 | 365.54 | 455.42 | 283.99 |
Cash & Short-Term Investments | 332.6 | 250.21 | 292.48 | 448.7 | 517.32 | 457.3 |
Cash Growth | 31.88% | -14.45% | -34.82% | -13.26% | 13.12% | -44.76% |
Other Receivables | - | 1.5 | 1.9 | 1.7 | 3.3 | 6 |
Receivables | - | 1.5 | 1.9 | 1.7 | 3.3 | 6 |
Prepaid Expenses | - | 6.04 | 9.01 | 8.72 | 8.2 | 8.02 |
Total Current Assets | - | 257.75 | 303.39 | 459.12 | 528.82 | 471.32 |
Property, Plant & Equipment | - | 112.73 | 131.26 | 163.18 | 196.43 | 181.02 |
Long-Term Investments | - | 8.04 | 80.67 | 3.65 | 79.47 | 370.18 |
Other Long-Term Assets | - | 37.39 | 33.39 | 16.9 | 16.86 | 16.11 |
Total Assets | - | 415.91 | 548.71 | 642.84 | 821.58 | 1,039 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | - | 4.27 | 5.39 | 5.9 | 13.89 | 10.26 |
Accrued Expenses | - | 17.64 | 21.55 | 21.98 | 29.73 | 29.65 |
Current Portion of Leases | - | 8.21 | 7.51 | 6.78 | 6 | 3.2 |
Current Unearned Revenue | - | - | - | 0.09 | 0.1 | 0.42 |
Other Current Liabilities | - | 2.4 | 1.07 | 2.34 | 4.02 | 4.65 |
Total Current Liabilities | - | 32.51 | 35.52 | 37.08 | 53.73 | 48.17 |
Long-Term Leases | - | 75.05 | 83.25 | 88.35 | 95.12 | 69.93 |
Other Long-Term Liabilities | - | 15.8 | 7.76 | 5.18 | 5.85 | 4.13 |
Total Liabilities | - | 123.36 | 126.53 | 130.6 | 154.7 | 122.23 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | - | 0.23 | 0.21 | 0.17 | 0.14 | 0.14 |
Additional Paid-In Capital | - | 2,303 | 2,242 | 2,075 | 1,912 | 1,822 |
Retained Earnings | - | -2,011 | -1,820 | -1,562 | -1,235 | -903.35 |
Comprehensive Income & Other | - | 0.27 | -0.09 | -0.96 | -9.93 | -2.57 |
Shareholders' Equity | 436.18 | 292.54 | 422.18 | 512.23 | 666.88 | 916.41 |
Total Liabilities & Equity | - | 415.91 | 548.71 | 642.84 | 821.58 | 1,039 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 79.01 | 83.25 | 90.76 | 95.12 | 101.12 | 73.13 |
Net Cash (Debt) | 253.6 | 166.96 | 201.72 | 353.58 | 416.2 | 384.17 |
Net Cash Growth | 51.81% | -17.23% | -42.95% | -15.05% | 8.34% | -50.37% |
Net Cash Per Share | 0.89 | 0.76 | 1.04 | 2.25 | 2.91 | 2.83 |
Filing Date Shares Outstanding | 346.09 | 243.78 | 217.26 | 169.09 | 144.5 | 142.75 |
Total Common Shares Outstanding | 346.09 | 229.41 | 212.21 | 168.64 | 144.44 | 142.62 |
Working Capital | - | 225.24 | 267.86 | 422.04 | 475.1 | 423.15 |
Book Value Per Share | 1.26 | 1.28 | 1.99 | 3.04 | 4.62 | 6.43 |
Tangible Book Value | 436.18 | 292.54 | 422.18 | 512.23 | 666.88 | 916.41 |
Tangible Book Value Per Share | 1.26 | 1.28 | 1.99 | 3.04 | 4.62 | 6.43 |
Machinery | - | 37.84 | 40.47 | 41.94 | 41.15 | 37.96 |
Construction In Progress | - | - | - | - | 0.03 | 0.04 |
Leasehold Improvements | - | 107.54 | 108.13 | 108.62 | 108.55 | 108.35 |